NASDAQ:HZNP Horizon Therapeutics Public (HZNP) News Today $115.69 0.00 (0.00%) (As of 09/29/2023 ET) Add Compare Share Share Today's Range$115.66▼$115.7550-Day Range$98.98▼$115.7452-Week Range$60.03▼$115.87Volume1.73 million shsAverage Volume3.29 million shsMarket Capitalization$26.49 billionP/E Ratio61.87Dividend YieldN/APrice Target$110.71 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHorizon Therapeutics Public (NASDAQ:HZNP) Hits New 12-Month High at $115.87americanbankingnews.com - September 29 at 5:18 AMHorizon Therapeutics Public (NASDAQ:HZNP) Upgraded at StockNews.comamericanbankingnews.com - September 27 at 3:58 AMBoard Member at Horizon Therapeutics Exercises Options Worth $2.31Mbenzinga.com - September 26 at 2:17 PMHorizon Therapeutics plc Named to U.S. News & World Report’s 2024 List of Best Companies to Work For in the Health Care Industryfinance.yahoo.com - September 26 at 9:17 AMHorizon Therapeutics Public Limited (NASDAQ:HZNP) Given Consensus Rating of "Hold" by Analystsamericanbankingnews.com - September 26 at 2:41 AMHorizon Therapeutics Public Limited (NASDAQ:HZNP) Receives $110.71 Average Target Price from Analystsamericanbankingnews.com - September 26 at 2:40 AMHorizon Therapeutics Public Limited (NASDAQ:HZNP) Shares Sold by Congress Wealth Management LLC DEmarketbeat.com - September 24 at 4:51 AMPalliser Capital UK Ltd Has $8.17 Million Stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP)marketbeat.com - September 21 at 3:38 PMHorizon Therapeutics plc Ranks Number One on the Fortune Best Workplaces in Biopharma 2023 Listfinance.yahoo.com - September 19 at 10:26 AMHealth care: FTC Chair Lina Khan to crack down on 'below radar' dealsfinance.yahoo.com - September 19 at 10:26 AMAtria Wealth Solutions Inc. Sells 2,756 Shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP)marketbeat.com - September 17 at 5:11 AMHorizon Therapeutics Public Limited (NASDAQ:HZNP) is Syquant Capital Sas' Largest Positionmarketbeat.com - September 15 at 4:39 PMQ32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia Areatafinance.yahoo.com - September 13 at 9:24 AMHorizon Therapeutics Public (NASDAQ:HZNP) Upgraded by StockNews.com to Strong-Buymarketbeat.com - September 13 at 6:28 AMHorizon Therapeutics Public Limited (NASDAQ:HZNP) is Governors Lane LP's 2nd Largest Positionmarketbeat.com - September 12 at 9:26 AMRenaissance Technologies LLC Purchases 1,693,400 Shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP)marketbeat.com - September 8 at 3:34 PMHorizon Therapeutics Public Limited (NASDAQ:HZNP) is Prosight Management LP's 9th Largest Positionmarketbeat.com - September 7 at 2:54 PM3 Growth Stocks to Buy in September (HZNP)marketbeat.com - September 6 at 10:55 AMHorizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of Arrangementfinance.yahoo.com - September 5 at 5:30 PMOxford Financial Group Ltd. Invests $273,000 in Horizon Therapeutics Public Limited (NASDAQ:HZNP)marketbeat.com - September 5 at 11:21 AMStockNews.com Lowers Horizon Therapeutics Public (NASDAQ:HZNP) to Buymarketbeat.com - September 5 at 3:30 AMHere's How Much $1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth Todaybenzinga.com - September 4 at 4:16 PM27,842 Shares in Horizon Therapeutics Public Limited (NASDAQ:HZNP) Purchased by FORA Capital LLCmarketbeat.com - September 3 at 10:58 AMHorizon Therapeutics plc and Amgen: Amgen and Horizon Therapeutics plc Resolve FTC Lawsuit, Clearing Path to Close Acquisitionfinanznachrichten.de - September 1 at 6:21 PMAllspring Global Investments Holdings LLC Decreases Stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP)marketbeat.com - September 1 at 4:13 PMShort Interest in Horizon Therapeutics Public Limited (NASDAQ:HZNP) Decreases By 7.7%marketbeat.com - September 1 at 2:56 PMHorizon Therapeutics Public (NASDAQ:HZNP) Downgraded to Hold at Jefferies Financial Groupmarketbeat.com - September 1 at 2:30 PMHow Much Pain Will Lower Medicare Prices Cause for Pharma Stocks? (HZNP)marketbeat.com - September 1 at 7:00 AMHorizon Therapeutics Public Limited (NASDAQ:HZNP) Given Consensus Recommendation of "Hold" by Brokeragesmarketbeat.com - September 1 at 2:39 AMFTC suspends challenge to Amgen-Horizon Therapeutics dealfinance.yahoo.com - August 28 at 2:11 PMUS FTC suspends challenge to block Amgen's $27.8 bln deal for Horizon Therapeuticsreuters.com - August 26 at 3:09 PMRamius Advisors LLC Purchases Shares of 141,528 Horizon Therapeutics Public Limited (NASDAQ:HZNP)marketbeat.com - August 25 at 3:34 PMHorizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy Groupsfinance.yahoo.com - August 23 at 7:11 PMKnott David M Jr Acquires 1,000 Shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP)marketbeat.com - August 23 at 2:56 PMCredit Suisse AG Has $40.85 Million Position in Horizon Therapeutics Public Limited (NASDAQ:HZNP)marketbeat.com - August 22 at 6:32 AMAthos Capital Ltd Raises Position in Horizon Therapeutics Public Limited (NASDAQ:HZNP)marketbeat.com - August 20 at 11:49 AMHorizon Therapeutics Public Limited (NASDAQ:HZNP) Stake Cut by First National Advisers LLCmarketbeat.com - August 18 at 1:01 PMHorizon Therapeutics: Can Investors Profit From Amgen Deal Confusion?seekingalpha.com - August 16 at 6:02 PMImproved Outlook For Horizon Therapeutics And Amgenseekingalpha.com - August 16 at 2:31 PMHorizon Therapeutics Public Limited (NASDAQ:HZNP) Shares Sold by GW&K Investment Management LLCmarketbeat.com - August 15 at 6:58 AMQ4 2023 Earnings Estimate for Horizon Therapeutics Public Limited (NASDAQ:HZNP) Issued By HC Wainwrightmarketbeat.com - August 14 at 4:28 AMHorizon Therapeutics Public Limited (NASDAQ:HZNP) Shares Purchased by GAM Holding AGmarketbeat.com - August 11 at 11:17 AMDrinks, Chips & Drugs: A Surprising List of 10-Year Stock Winners (HZNP)marketbeat.com - August 11 at 7:09 AMAnalysts Offer Insights on Healthcare Companies: Horizon Therapeutics (HZNP) and Biogen (BIIB)markets.businessinsider.com - August 9 at 1:23 PMHorizon Therapeutics (HZNP) Receives a Hold from H.C. Wainwrightmarkets.businessinsider.com - August 9 at 8:22 AMNew York Life Investment Management LLC Purchases 249,963 Shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP)marketbeat.com - August 8 at 9:43 PMHorizon Therapeutics plc Reports Second-Quarter 2023 Financial Resultsfinance.yahoo.com - August 8 at 11:13 AMIs Growth Priced into Amgen Stock after Earnings Beat? (HZNP)marketbeat.com - August 7 at 7:00 AMHorizon Therapeutics Public Limited (NASDAQ:HZNP) Receives Average Rating of "Hold" from Analystsmarketbeat.com - August 7 at 2:45 AMAmgen raises full-year earnings and revenue outlookfinance.yahoo.com - August 4 at 8:05 PM Get Horizon Therapeutics Public News Delivered to You Automatically Sign up to receive the latest news and ratings for HZNP and its competitors with MarketBeat's FREE daily newsletter. Email Address HZNP Media Mentions By Week HZNP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HZNP News Sentiment▼0.830.70▲Average Medical News Sentiment HZNP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HZNP Articles This Week▼85▲HZNP Articles Average Week Get Horizon Therapeutics Public News Delivered to You Automatically Sign up to receive the latest news and ratings for HZNP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: JAZZ News ZTS News GMAB News ALNY News BGNE News VTRS News TEVA News RDY News VRNA News LEGN News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:HZNP) was last updated on 10/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Horizon Therapeutics Public Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.